3 results
Approved WMOCompleted
The primary objective of the study is to demonstrate the safety of the investigational device (GRADION* Hip Total Cartilage Replacement (TCR)* ).
Approved WMOCompleted
To determine the optimal patient observation and Avastin injection schedule.
Approved WMOCompleted
To assess the effect of switching CML patients, who have been treated with imatinib *2 years and who have stable detectable molecular residual disease above 0.01% (IS), to the combination of Nilotinib and PegIFN, in terms of the proportion of…